|

S&P 500 top movers: Alexion Pharmaceuticals Inc (ALXN: NASDAQ) up more than 30%

  • S&P 500 lost its traction after starting the day decisively higher.
  • Alexion Pharmaceuticals Inc (ALXN: NASDAQ) post impressive gains on Monday.
  • Energy stocks suffer heavy losses at the start of the week.

The S&P 500 Index (SPX) opened sharply higher and gained nearly 1% in the first hour of the session on Monday. However, the negative shift witnessed in risk sentiment weighed on major equity indexes and the SPX was last seen gaining only 0.1% on the day at 3,667.

S&P 500 top movers

Over the weekend, AstraZeneca PLC (AZN: NASDAQ) announced that it will acquire US-based biotech company Alexion Pharmaceuticals Inc (ALXN: NASDAQ) for about $39 billion. This development caused AZN to suffer heavy losses and provided a strong boost to ALXN. As of writing, ALXN was the biggest daily percentage gainer of the day, rising 30.5% to trade at its highest level in more than four years at $157.96. 

Incyte Corp (INCY: NASDAQ), Mosaic Co (MOS: NYSE) and ABIOMED Inc (ABMD: NASDAQ) shares are among the other top performers on Monday, up between 4.5% and 7.2%.

On the other hand, major energy stocks are falling sharply on Monday. Earlier in the day, OPEC in its monthly report revised its forecast for 2021 global energy demand recovery lower due to coronavirus uncertainty and mild winter expectations. At the moment, Occidental Petroleum Corp (OXY: NYSE), Diamondback Energy Inc (FANG: NASDAQ) and Marathon Petroleum Corp (MPC: NYSE) stocks are losing between 6.8% and 3.7%. 

Author

Eren Sengezer

As an economist at heart, Eren Sengezer specializes in the assessment of the short-term and long-term impacts of macroeconomic data, central bank policies and political developments on financial assets.

More from Eren Sengezer
Share:

Editor's Picks

EUR/USD sticks to positive bias above 1.1800 as trade jitters undermine USD

The EUR/USD pair builds on the previous day's modest gains and attracts some buyers for the second straight day on Thursday amid a softer US Dollar. Spot prices, however, lack bullish conviction and trade around the 1.1815-1.1820 area during the Asian session, up 0.10% for the day.

GBP/USD bounces as soft CPI boosts BoE cut bets

GBP/USD rose 0.42% on Wednesday, recovering toward 1.3600 in a session shaped by softer-than-expected UK inflation data and broad US Dollar weakness. The pair had been consolidating in a tight range between about 1.3450 and 1.3520 for the past few days following the sharp pullback from the late-January high near 1.3870, and Wednesday's move pushed price action back onto the high side of key moving averages.

Gold retakes $5,200 amid sustained haven demand, softer USD

Gold attracts some buyers for the second straight day as trade jitters and geopolitical tensions persist ahead of the US-Iran nuclear talks, which underpin demand for safe-haven assets. Additionally, a softer US Dollar further supports the bullion, though the underlying bullish sentiment could cap gains. Bulls might also opt to wait for acceptance above the $5,200 mark before positioning for any meaningful appreciating move.

Michael Saylor unveils Bitcoin-backed "Digital Credit" vision at Strategy World

Strategy CEO Michael Saylor delivered a keynote titled "Digital Credit" on Tuesday at Strategy World, positioning Bitcoin as the foundation of a new financial system built on what he described as "digital capital."

Nvidia delivers another monster earnings report, and forecasts big things to come

It was another monster earnings report from Nvidia for fiscal Q4. Revenues were $68.1bn, smashing estimates of $65bn. Gross profit margin was a healthy 75%, up from 73.5% in the prior quarter, and the outlook for this quarter was monstrous.

Cosmos Hub Price Forecast: ATOM rebounds slightly, bearish outlook remains intact

Cosmos Hub (ATOM) price rebounds, trading above $2.05 at the time of writing on Wednesday, after undergoing a sharp correction since last week. Weakening on-chain and derivatives data support a bearish outlook, while technical analysis remains unfavorable.